Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-028424

CEO and CFO bought 4,100 shares at $12.62 ($51,742)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-12-18 Purchase +4,100 $12.62 $51,742 5,592,202 D: show line 1 in the form
Open-market purchases · 4,100 sh · avg $12.62 · $51,742
Loading xslF345X05/ownership.xml…